| Title |
Clinical Characteristics and Treatment Outcomes of Autoimmune-Associated Hemophagocytic Syndrome in Adults
|
| Creator |
Murakawa Yohko
|
| Source Title |
ARTHRITIS & RHEUMATOLOGY
|
| Volume | 66 |
| Issue | 8 |
| Start Page | 2297 |
| End Page | 2307 |
| Journal Identifire |
ISSN 2326-5191
EISSN 2326-5205
|
| Language |
eng
|
| Resource Type | journal article |
| Publisher |
WILEY
|
| Date of Issued | 2014-08 |
| Access Rights | metadata only access |
| Relation |
[DOI]
10.1002/art.38672
[PMID]
24756912
|
| Remark | Dr. Kumakura has received speaking fees from Dainippon Sumitomo Pharma (less than $10,000). Dr. Murakawa has received speaking fees from Chugai Pharma, Eisai, Mitsubishi Tanabe Pharma, Pfizer, Astellas Pharma, Takeda Pharma, Janssen Pharma, Santen Pharma, Bristol-Myers Squibb, Ono Pharma, Kissei Pharma, Actelion Pharma, and AbbVie Japan and research grant support from Teijin Pharma, Astellas Pharma, Bristol-Myers Squibb, Mitsubishi Tanabe Pharma, Chugai Pharma, Takeda Pharma, and Eisai (less than $10,000 each). |
